Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis
Rationale There is no adequate explanation for gender‐based differences in rates of mortality and of deterioration in pulmonary function in cystic fibrosis (CF) patients. One potential explanation is that gender hormones (sex steroids) may modulate the severity of CF lung disease, the principal caus...
Gespeichert in:
Veröffentlicht in: | Pediatric pulmonology 2007-06, Vol.42 (6), p.519-524 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 524 |
---|---|
container_issue | 6 |
container_start_page | 519 |
container_title | Pediatric pulmonology |
container_volume | 42 |
creator | Sweezey, Neil B. Smith, David Corey, Mary Ellis, Lynda Carpenter, Susan Tullis, D. Elizabeth Durie, Peter O'Brodovich, Hugh M. |
description | Rationale
There is no adequate explanation for gender‐based differences in rates of mortality and of deterioration in pulmonary function in cystic fibrosis (CF) patients. One potential explanation is that gender hormones (sex steroids) may modulate the severity of CF lung disease, the principal cause of mortality in CF, by altering respiratory transepithelial ion transport.
Objective
To determine whether respiratory epithelial ion transport varied during the menstrual cycle of CF females.
Methods
The nasal transepithelial electrical potential difference (NPD) was determined as a measure of ion transport across human respiratory epithelium, coincident with measurements of endogenous serum hormone levels in the luteal and follicular phases of the menstrual cycle in CF females aged 16–22 years.
Results
The component of the NPD that is insensitive to the Na+ transport blocker amiloride, but not the amiloride‐sensitive component, changed in association with endogenous, menstrual cycle‐induced changes in serum levels of progesterone and estrogen (P = 0.02, n = 7, paired t‐test). Measurements using Cl− free perfusates suggested that the changes are not a result of Cl− conductance.
Conclusions
Our results suggest that in CF respiratory epithelium amiloride‐insensitive, but not amiloride‐sensitive, ion transport is altered by female gender hormones in vivo. We speculate that amiloride‐insensitive ion transport may contribute to the regulation of human airway surface fluid. Pediatr Pulmonol. 2007; 42:519–524. © 2007 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/ppul.20624 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70463271</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70463271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4014-bb795566ba1fca2d2e1327241cd2808927b621886102832274242286d8e7ebc53</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EotvChR-AcuKAlGJPHNs5VhUsSCvogarcLMeZqAP5wnZa9t_jdhe4cZqR5nkfjV7GXgl-LjiHd8uyDufAFcgnbCN405RcNuop2xhd16UyqjphpzF-5zzfGvGcnQgtVSNq2DB_MdIwB-qwpCniFCnRHRaTi24oljnhlChvHfU9Bpw8FncuEMbintJtkW6xGHMohTVDfu8HLGjKS0zki57aMEeKL9iz3g0RXx7nGbv-8P7r5cdy92X76fJiV3rJhSzbVjd1rVTrRO8ddICiAg1S-A4MNw3oVoEwRgkOpgLQEiSAUZ1Bja2vqzP25uBdwvxzxZjsSNHjMLgJ5zVazaXKRpHBtwfQ5_9iwN4ugUYX9lZw-1CpfajUPlaa4ddH69qO2P1Djx1mQByAexpw_x-Vvbq63v2RlocMxYS__mZc-GGVrnRtbz5vbb3d3XyrzNZW1W8z3pEb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70463271</pqid></control><display><type>article</type><title>Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Sweezey, Neil B. ; Smith, David ; Corey, Mary ; Ellis, Lynda ; Carpenter, Susan ; Tullis, D. Elizabeth ; Durie, Peter ; O'Brodovich, Hugh M.</creator><creatorcontrib>Sweezey, Neil B. ; Smith, David ; Corey, Mary ; Ellis, Lynda ; Carpenter, Susan ; Tullis, D. Elizabeth ; Durie, Peter ; O'Brodovich, Hugh M.</creatorcontrib><description>Rationale
There is no adequate explanation for gender‐based differences in rates of mortality and of deterioration in pulmonary function in cystic fibrosis (CF) patients. One potential explanation is that gender hormones (sex steroids) may modulate the severity of CF lung disease, the principal cause of mortality in CF, by altering respiratory transepithelial ion transport.
Objective
To determine whether respiratory epithelial ion transport varied during the menstrual cycle of CF females.
Methods
The nasal transepithelial electrical potential difference (NPD) was determined as a measure of ion transport across human respiratory epithelium, coincident with measurements of endogenous serum hormone levels in the luteal and follicular phases of the menstrual cycle in CF females aged 16–22 years.
Results
The component of the NPD that is insensitive to the Na+ transport blocker amiloride, but not the amiloride‐sensitive component, changed in association with endogenous, menstrual cycle‐induced changes in serum levels of progesterone and estrogen (P = 0.02, n = 7, paired t‐test). Measurements using Cl− free perfusates suggested that the changes are not a result of Cl− conductance.
Conclusions
Our results suggest that in CF respiratory epithelium amiloride‐insensitive, but not amiloride‐sensitive, ion transport is altered by female gender hormones in vivo. We speculate that amiloride‐insensitive ion transport may contribute to the regulation of human airway surface fluid. Pediatr Pulmonol. 2007; 42:519–524. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 8755-6863</identifier><identifier>EISSN: 1099-0496</identifier><identifier>DOI: 10.1002/ppul.20624</identifier><identifier>PMID: 17469152</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; Amiloride - pharmacology ; Case-Control Studies ; Cystic Fibrosis - blood ; Cystic Fibrosis - physiopathology ; Estrogens - blood ; Female ; Follicular Phase - blood ; Humans ; ion transport ; Ion Transport - drug effects ; Ion Transport - physiology ; Luteal Phase - blood ; Membrane Potentials - drug effects ; Membrane Potentials - physiology ; Menstrual Cycle - blood ; Menstrual Cycle - physiology ; Nasal Mucosa - cytology ; Nasal Mucosa - drug effects ; Nasal Mucosa - physiology ; Progesterone - blood ; Sex Factors ; sex steroids ; Sodium Channel Blockers - pharmacology ; transepithelial voltage</subject><ispartof>Pediatric pulmonology, 2007-06, Vol.42 (6), p.519-524</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><rights>(c) 2007 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4014-bb795566ba1fca2d2e1327241cd2808927b621886102832274242286d8e7ebc53</citedby><cites>FETCH-LOGICAL-c4014-bb795566ba1fca2d2e1327241cd2808927b621886102832274242286d8e7ebc53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fppul.20624$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fppul.20624$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17469152$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sweezey, Neil B.</creatorcontrib><creatorcontrib>Smith, David</creatorcontrib><creatorcontrib>Corey, Mary</creatorcontrib><creatorcontrib>Ellis, Lynda</creatorcontrib><creatorcontrib>Carpenter, Susan</creatorcontrib><creatorcontrib>Tullis, D. Elizabeth</creatorcontrib><creatorcontrib>Durie, Peter</creatorcontrib><creatorcontrib>O'Brodovich, Hugh M.</creatorcontrib><title>Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis</title><title>Pediatric pulmonology</title><addtitle>Pediatr. Pulmonol</addtitle><description>Rationale
There is no adequate explanation for gender‐based differences in rates of mortality and of deterioration in pulmonary function in cystic fibrosis (CF) patients. One potential explanation is that gender hormones (sex steroids) may modulate the severity of CF lung disease, the principal cause of mortality in CF, by altering respiratory transepithelial ion transport.
Objective
To determine whether respiratory epithelial ion transport varied during the menstrual cycle of CF females.
Methods
The nasal transepithelial electrical potential difference (NPD) was determined as a measure of ion transport across human respiratory epithelium, coincident with measurements of endogenous serum hormone levels in the luteal and follicular phases of the menstrual cycle in CF females aged 16–22 years.
Results
The component of the NPD that is insensitive to the Na+ transport blocker amiloride, but not the amiloride‐sensitive component, changed in association with endogenous, menstrual cycle‐induced changes in serum levels of progesterone and estrogen (P = 0.02, n = 7, paired t‐test). Measurements using Cl− free perfusates suggested that the changes are not a result of Cl− conductance.
Conclusions
Our results suggest that in CF respiratory epithelium amiloride‐insensitive, but not amiloride‐sensitive, ion transport is altered by female gender hormones in vivo. We speculate that amiloride‐insensitive ion transport may contribute to the regulation of human airway surface fluid. Pediatr Pulmonol. 2007; 42:519–524. © 2007 Wiley‐Liss, Inc.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Amiloride - pharmacology</subject><subject>Case-Control Studies</subject><subject>Cystic Fibrosis - blood</subject><subject>Cystic Fibrosis - physiopathology</subject><subject>Estrogens - blood</subject><subject>Female</subject><subject>Follicular Phase - blood</subject><subject>Humans</subject><subject>ion transport</subject><subject>Ion Transport - drug effects</subject><subject>Ion Transport - physiology</subject><subject>Luteal Phase - blood</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - physiology</subject><subject>Menstrual Cycle - blood</subject><subject>Menstrual Cycle - physiology</subject><subject>Nasal Mucosa - cytology</subject><subject>Nasal Mucosa - drug effects</subject><subject>Nasal Mucosa - physiology</subject><subject>Progesterone - blood</subject><subject>Sex Factors</subject><subject>sex steroids</subject><subject>Sodium Channel Blockers - pharmacology</subject><subject>transepithelial voltage</subject><issn>8755-6863</issn><issn>1099-0496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EotvChR-AcuKAlGJPHNs5VhUsSCvogarcLMeZqAP5wnZa9t_jdhe4cZqR5nkfjV7GXgl-LjiHd8uyDufAFcgnbCN405RcNuop2xhd16UyqjphpzF-5zzfGvGcnQgtVSNq2DB_MdIwB-qwpCniFCnRHRaTi24oljnhlChvHfU9Bpw8FncuEMbintJtkW6xGHMohTVDfu8HLGjKS0zki57aMEeKL9iz3g0RXx7nGbv-8P7r5cdy92X76fJiV3rJhSzbVjd1rVTrRO8ddICiAg1S-A4MNw3oVoEwRgkOpgLQEiSAUZ1Bja2vqzP25uBdwvxzxZjsSNHjMLgJ5zVazaXKRpHBtwfQ5_9iwN4ugUYX9lZw-1CpfajUPlaa4ddH69qO2P1Djx1mQByAexpw_x-Vvbq63v2RlocMxYS__mZc-GGVrnRtbz5vbb3d3XyrzNZW1W8z3pEb</recordid><startdate>200706</startdate><enddate>200706</enddate><creator>Sweezey, Neil B.</creator><creator>Smith, David</creator><creator>Corey, Mary</creator><creator>Ellis, Lynda</creator><creator>Carpenter, Susan</creator><creator>Tullis, D. Elizabeth</creator><creator>Durie, Peter</creator><creator>O'Brodovich, Hugh M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200706</creationdate><title>Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis</title><author>Sweezey, Neil B. ; Smith, David ; Corey, Mary ; Ellis, Lynda ; Carpenter, Susan ; Tullis, D. Elizabeth ; Durie, Peter ; O'Brodovich, Hugh M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4014-bb795566ba1fca2d2e1327241cd2808927b621886102832274242286d8e7ebc53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Amiloride - pharmacology</topic><topic>Case-Control Studies</topic><topic>Cystic Fibrosis - blood</topic><topic>Cystic Fibrosis - physiopathology</topic><topic>Estrogens - blood</topic><topic>Female</topic><topic>Follicular Phase - blood</topic><topic>Humans</topic><topic>ion transport</topic><topic>Ion Transport - drug effects</topic><topic>Ion Transport - physiology</topic><topic>Luteal Phase - blood</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - physiology</topic><topic>Menstrual Cycle - blood</topic><topic>Menstrual Cycle - physiology</topic><topic>Nasal Mucosa - cytology</topic><topic>Nasal Mucosa - drug effects</topic><topic>Nasal Mucosa - physiology</topic><topic>Progesterone - blood</topic><topic>Sex Factors</topic><topic>sex steroids</topic><topic>Sodium Channel Blockers - pharmacology</topic><topic>transepithelial voltage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sweezey, Neil B.</creatorcontrib><creatorcontrib>Smith, David</creatorcontrib><creatorcontrib>Corey, Mary</creatorcontrib><creatorcontrib>Ellis, Lynda</creatorcontrib><creatorcontrib>Carpenter, Susan</creatorcontrib><creatorcontrib>Tullis, D. Elizabeth</creatorcontrib><creatorcontrib>Durie, Peter</creatorcontrib><creatorcontrib>O'Brodovich, Hugh M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric pulmonology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sweezey, Neil B.</au><au>Smith, David</au><au>Corey, Mary</au><au>Ellis, Lynda</au><au>Carpenter, Susan</au><au>Tullis, D. Elizabeth</au><au>Durie, Peter</au><au>O'Brodovich, Hugh M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis</atitle><jtitle>Pediatric pulmonology</jtitle><addtitle>Pediatr. Pulmonol</addtitle><date>2007-06</date><risdate>2007</risdate><volume>42</volume><issue>6</issue><spage>519</spage><epage>524</epage><pages>519-524</pages><issn>8755-6863</issn><eissn>1099-0496</eissn><abstract>Rationale
There is no adequate explanation for gender‐based differences in rates of mortality and of deterioration in pulmonary function in cystic fibrosis (CF) patients. One potential explanation is that gender hormones (sex steroids) may modulate the severity of CF lung disease, the principal cause of mortality in CF, by altering respiratory transepithelial ion transport.
Objective
To determine whether respiratory epithelial ion transport varied during the menstrual cycle of CF females.
Methods
The nasal transepithelial electrical potential difference (NPD) was determined as a measure of ion transport across human respiratory epithelium, coincident with measurements of endogenous serum hormone levels in the luteal and follicular phases of the menstrual cycle in CF females aged 16–22 years.
Results
The component of the NPD that is insensitive to the Na+ transport blocker amiloride, but not the amiloride‐sensitive component, changed in association with endogenous, menstrual cycle‐induced changes in serum levels of progesterone and estrogen (P = 0.02, n = 7, paired t‐test). Measurements using Cl− free perfusates suggested that the changes are not a result of Cl− conductance.
Conclusions
Our results suggest that in CF respiratory epithelium amiloride‐insensitive, but not amiloride‐sensitive, ion transport is altered by female gender hormones in vivo. We speculate that amiloride‐insensitive ion transport may contribute to the regulation of human airway surface fluid. Pediatr Pulmonol. 2007; 42:519–524. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17469152</pmid><doi>10.1002/ppul.20624</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8755-6863 |
ispartof | Pediatric pulmonology, 2007-06, Vol.42 (6), p.519-524 |
issn | 8755-6863 1099-0496 |
language | eng |
recordid | cdi_proquest_miscellaneous_70463271 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
subjects | Adolescent Adult Amiloride - pharmacology Case-Control Studies Cystic Fibrosis - blood Cystic Fibrosis - physiopathology Estrogens - blood Female Follicular Phase - blood Humans ion transport Ion Transport - drug effects Ion Transport - physiology Luteal Phase - blood Membrane Potentials - drug effects Membrane Potentials - physiology Menstrual Cycle - blood Menstrual Cycle - physiology Nasal Mucosa - cytology Nasal Mucosa - drug effects Nasal Mucosa - physiology Progesterone - blood Sex Factors sex steroids Sodium Channel Blockers - pharmacology transepithelial voltage |
title | Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A37%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amiloride-insensitive%20nasal%20potential%20difference%20varies%20with%20the%20menstrual%20cycle%20in%20cystic%20fibrosis&rft.jtitle=Pediatric%20pulmonology&rft.au=Sweezey,%20Neil%20B.&rft.date=2007-06&rft.volume=42&rft.issue=6&rft.spage=519&rft.epage=524&rft.pages=519-524&rft.issn=8755-6863&rft.eissn=1099-0496&rft_id=info:doi/10.1002/ppul.20624&rft_dat=%3Cproquest_cross%3E70463271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70463271&rft_id=info:pmid/17469152&rfr_iscdi=true |